Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma

World J Pediatr. 2023 Dec 7. doi: 10.1007/s12519-023-00769-9. Online ahead of print.NO ABSTRACTPMID:38060141 | DOI:10.1007/s12519-023-00769-9
Source: World Journal of Pediatrics : WJP - Category: Pediatrics Authors: Source Type: research